GSK PLC closed 11.54% below its 52-week high of £16.79, which the company reached on September 9th.

Mumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Chinmay Sharma, Executive Vice President - ...

Stephen Hemsley returned to the top job last month after the healthcare giant reported its first earnings miss since 2008.

(Alliance News) - GSK PLC on Monday announced the US Food & Drug Administration has accepted for review the new drug application for its liver disease treatment, linerixibat.

GSK PLC closed 14.69% below its 52-week high of £17.67, which the company reached on May 31st.

Stocks of several companies, including Advani Hotels & Resorts (India), Bajaj Finance, GlaxoSmithKline Pharmaceuticals, ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

British drugmaker GSK is preparing for potential new U.S. tariffs on its medicines and can handle the challenge, the company’s leader said Wednesday. “I would say we’ve been preparing, we have what it ...

GSK stopped a Phase 3 trial for its investigational oral treatment for complicated urinary tract infections following positive data. The U.K. pharma company said Wednesday that the decision to cancel ...

Formerly known as GlaxoSmithKline, GSK plc (NYSE:GSK) is a global biopharma company that develops and distributes a range of vaccines, medications, and consumer health items. It is based in the United ...

The company, whose primary activities include ... we disclosed that the GSK UK Group has informed GlaxoSmithKline Consumer Nigeria PLC of its strategic intent to cease commercialisation of its ...

GlaxoSmithKline Consumer Nigeria Plc was incorporated in 1971. 46.4 per cent of the shares of the Company are held by Setfirst Limited and Smithkline Beecham Limited (both incorporated in the ...